Skip to main content
. 2020 Oct 7;36(4):917–925. doi: 10.1007/s00467-020-04751-9

Fig. 3.

Fig. 3

Evolution of CFH-Ab titers over 5-year follow-up period. Steady decrease of available CFH-Ab titers from disease onset up to 5-year follow-up (at 5 years, 55% of patients with CFH-Ab titers under cut-off of 100 AU/ml)